Liberia will receive an
untested experimental drug, Zmapp, to treat people infected with Ebola, the
Liberian government says.
The news came as medical ethics specialists met in Geneva to explore the use of such new treatments.
The World Health Organization, which is hosting the meeting, says some 1,013 have died from Ebola in West Africa.
US government officials said their role had been to put Liberian officials in contact with Zmapp maker Mapp Biopharmaceutical.
No comments:
Post a Comment
Disclaimer: All comments and opinions on any part of this blog/stories are not that of Olusegun Akinleye but strictly that of the readers/visitors.
For complaints, advert placements and tip-offs, contact me:
Email: mypenspeaks@gmail.com